Table 1. Demographic and medical characteristics of participants, by engagement group.
| Non-engaged users (n=59) | Low-engaged users (n=113) | Moderate-highly engaged users (n=124) | All users combined (n=296) | Between-group differences | |
|---|---|---|---|---|---|
| Age, x̄years (SD) | 56.1 (10.8) | 53.0 (11.9) | 53.5 (9.8) | 53.8 (10.8) | ns |
| Sex, n (%) | |||||
| Female | 46 (78.0 %) | 81 (71.7 %) | 103 (83.1 %) | 230 (77.7 %) | ns |
| Male | 13 (22.0 %) | 32 (28.3 %) | 21 (16.9 %) | 66 (22.3 %) | |
| Ethnicity, n (%) | |||||
| White (%) | 54 (91.5 %) | 101 (89.4 %) | 103 (83.1 %) | 258 (87.2 %) | ns |
| Latino (%) | 2 (3.4 %) | 5 (4.4 %) | 7 (5.6 %) | 14 (4.7 %) | |
| African-American (%) | 1 (1.7 %) | 4 (3.5 %) | 6 (4.8 %) | 11 (3.7 %) | |
| Other (%) | 2 (3.4 %) | 3 (2.7 %) | 8 (6.5 %) | 13 (4.4 %) | |
| Education, years (SD) | 15.4 (3.3) | 15.6 (2.5) | 16.0 (2.7) | 15.7 (2.7) | ns |
| Annual household income, dollars/year (SD) | 95,500 (120,884) | 92,400 (81,940) | 93,000 (94,240) | 93,270 (95,670) | ns |
| Cancer type, n (%) | ns | ||||
| Breast | 28 (47.5 %) | 47 (41.6 %) | 59 (47.6 %) | 134 (45.3 %) | |
| Prostate | 7 (11.9 %) | 20 (17.7 %) | 14 (11.3 %) | 41 (13.9 %) | |
| Colorectal | 4 (6.8 %) | 4 (3.5 %) | 4 (3.2 %) | 12 (4.1 %) | |
| Female reproductive | 2 (3.4 %) | 6 (5.3 %) | 10 (8.1 %) | 18 (6.1 %) | |
| Hematologic | 1 (1.7 %) | 6 (5.3 %) | 3 (2.4 %) | 10 (3.4 %) | |
| Urinary | 1 (1.7 %) | 0 (0 %) | 0 (0 %) | 1 (0.3 %) | |
| Melanoma | 1 (1.7 %) | 2 (1.8 %) | 4 (3.2 %) | 7 (2.4 %) | |
| Lung | 1 (1.7 %) | 0 (0 %) | 1 (0.8 %) | 2 (0.7 %) | |
| Other | 9 (15.3 %) | 22 (19.5 %) | 19 (15.3 %) | 50 (16.9 %) | |
| Multiple cancers | 5 (8.5 %) | 6 (5.3 %) | 10 (8.1 %) | 21 (7.1 %) | |
| Cancer spread | |||||
| No spread (%) | 30 (50.8 %) | 71 (62.8 %) | 71 (57.3 %) | 172 (58.1 %) | ns |
| Spread to lymph tissue (%) | 10 (16.9 %) | 22 (19.5 %) | 19 (15.3 %) | 51 (17.2 %) | |
| Regional metastasis (%) | 7 (11.9 %) | 8 (7.1 %) | 15 (12.1 %) | 30 (10.1 %) | |
| Distant metastasis (%) | 12 (20.3 %) | 12 (10.6 %) | 19 (15.3 %) | 43 (14.5 %) | |
ns=not significant